scispace - formally typeset
Open AccessJournal ArticleDOI

Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction

Reads0
Chats0
TLDR
There is no clearly demonstrable mortality benefit conferred by MVA for significant MR with severe LV dysfunction, and a prospective randomized control trial is warranted for further study of mortality with MVA in this population.
About
This article is published in Journal of the American College of Cardiology.The article was published on 2005-02-01 and is currently open access. It has received 637 citations till now. The article focuses on the topics: Mitral valve annuloplasty & Mitral regurgitation.

read more

Citations
More filters
Journal ArticleDOI

Sucesso da terapêutica de ressincronização cardíaca num doente com insuficiência cardíaca e regurgitação mitral secundária a doença isquémica: Importância do septal flash

TL;DR: Na nossa experiencia, a presenca deste movimento septal que tem como substrato dessincronia intraventricular de predominio radial, parece ser um marcador de resposta a CRT, pelo que, ponderados os riscos/beneficios da terapeutica cirurgica mitral sem revascularizacao associada, optou-se por esta ultima.
Book ChapterDOI

Future Perspectives of Catheter-Based Treatment in Valvular Heart Diseases

TL;DR: In this chapter the potentials and drawbacks of the present and emerging TVT technology are focused on and some of the future lines of research and applications are outlined.

Editorial Comment The Treatment of Ischemic Heart Failure With Surgical Ventricular Restoration (SVR): New Evidence of Benefit

TL;DR: Experimental and clinical studies support the hypothesis that increased ventricular volume is directly related to increased morbidity and mortality and suggest that surgical ventricular restoration, which can achieve a greater amount of volume reduction than medical therapy, may lead to a corresponding greater reduction in mortality.
References
More filters
Journal ArticleDOI

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

TL;DR: Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
Journal ArticleDOI

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

TL;DR: In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.
Journal ArticleDOI

Modern Applied Statistics with S-Plus.

W. N. Venables, +1 more
- 01 Dec 1996 - 
Related Papers (5)